ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q2SCImago #14,832Diamond OAHybrid

Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy

Acronym:rbfa
•
Identifier (ISSN):0102-695X(Print)/1981-528X(Online)
•
Publisher:Springer International Publishing
Former Names:
REV BRAS FARMACOGN
Clarivate JCR Index Advisory: Name Changed (Active in JCR)
Clarivate IF (2026)
1.7↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy

WoS Q4
01341.620181.7520191.4120202.0120212.4620221.620231.420241.620251.72026
Annual Impact Factor Metric
Current (2026):1.7
Scopus SJR & RankScopus Q2
0.377
#14,832

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
68

68 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate7.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
100articles/year
10.56% Gold OA•77.78% Original Research

Aims & Scope

The Brazilian Journal of Pharmacognosy is a scientific journal edited and published by the Brazilian Society of Pharmacognosy, an association that brings together researchers, students and professionals who study and investigate the physical, chemical and biological drugs, especially those of vegetable origin, substances isolated and such as the potential source of drugs of natural origin. It is available in printed form for its members and subscribers and openly on the Internet in all your numbers and content. The articles published are original research contributions. To evaluate the work use is made of international standards and is held by the ad hoc advisers, which reflects the quality and credibility of the journal. The BJP is published since 1986.

Topics Covered (Recognized by AI)
Biology89%Medicine78.4%Chemistry76.7%Botany61.5%Traditional medicine58.2%Biochemistry52.8%Organic chemistry50.2%Ecology42.5%Genetics37.3%Internal medicine28.5%Chromatography25.7%Pharmacology21.2%Physics20.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CHEMISTRY, MEDICINAL

Q4
Rank58/72
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank267/356
IndexSCIE
JCISCIE2026

CHEMISTRY, MEDICINAL

Q4
Rank62/72
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank291/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.7
Articles / Year70
Total Citations8
2025
IF1.6
Articles / Year111
Total Citations111
2024
IF1.4
Articles / Year107
Total Citations298
2023
IF1.6
Articles / Year151
Total Citations786
2022
IF2.464
Articles / Year124
Total Citations882

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,832Scopus Q2Diamond OASCImago Profile
Scopus Coverage:2007-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.377

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.04

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations747
3-Year Documents360
Citable Documents360

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区CHEMISTRY, MEDICINAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy (acronym: rbfa, ISSN: 0102-695X) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Springer International Publishing in England since 2015. The periodical holds a Journal Impact Factor (JIF) of 1.70, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.377 (Q2), an H-index of 68.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 100 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English, Portuguese
Frequency
Quarterly
Founding Year
2015
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SOC BRASILEIRA FARMACOGNOSIA, C/O PROF JOSE MARIA BARBOSA FILHO, UNIV FEDERAL PARAIBA, LAB TECNOLOGIA FARMACEUTICA, JOAO PESSOA, BRAZIL, 58051-970PB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 0f602279-6ae2-443b-85cc-5bbc40b75914
Database Updated: 2026-09-28